Levodopa-based device-aided therapies for the treatment of advanced Parkinson's disease: a social return on investment analysis
IntroductionParkinson's disease (PD) is an incurable, progressive, neurodegenerative disorder. As PD advances and symptoms progress, patients become increasingly dependent on family and carers. Traditional cost-effectiveness analyses (CEA) only consider patient and payer-related outcomes, faili...
Saved in:
Main Authors: | Inez Denham (Author), Roxanne Maurin (Author), Irene Deltetto (Author), Anna Stefanie Mikolaizak (Author), Jenny B. Waern (Author), Colman Taylor (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategies for the implementation of the living guidelines for cochlear implantation in adults
by: Ángel Ramos-Macías, et al.
Published: (2023) -
Levodopa versus levodopa sparing in early parkinson's disease: can we meet halfway?
by: Mayela Rodríguez-Violante, et al.
Published: (2024) -
Levodopa-induced Dyskinesias in Parkinson's Disease: Current Knowledge and Future Scenarios
by: Francesca Morgante
Published: (2015) -
Parkinson's disease: general features, effects of levodopa treatment and future directions
by: Marco Aurelio M Freire, et al.
Published: (2010) -
Levodopa in Parkinson's Disease: A Review of Population Pharmacokinetics/Pharmacodynamics Analysis
by: Amélie Marsot, et al.
Published: (2017)